Filtered By:
Source: International Journal of Cardiology
Condition: Heart Disease
This page shows you your search results in order of date.
Order by Relevance | Date
Total 77 results found since Jan 2013.
Risk of cardioembolic ischemic events and relation to atrial fibrillation/flutter in patients with arrhythmogenic cardiomyopathy during a long-term follow-up
This study sought to determine the occurrence of cardioembolic ischemic events (CIEs) in ACM patients and to identify clinical and imaging predictors of CIEs.
Source: International Journal of Cardiology - July 21, 2023 Category: Cardiology Authors: Elisabetta Toso, Francesca De Lio, Pier Paolo Bocchino, Claudia Raineri, Francesco Fioravanti, Elena Maria Richiardi, Gianluca Marcelli, Tania Sacco, Carla Giustetto, Fiorenzo Gaita Source Type: research
Simplifying the approach to classical low-flow low-gradient severe aortic stenosis: A renewed emphasis on the resting transthoracic echocardiogram
Aortic stenosis (AS) represents the most commonly encountered valvular heart disease. Traditionally, severe AS is defined by an aortic valve area (AVA) less than or equal to 1.0 cm2 and mean aortic valve gradient (MG) greater than or equal to 40 mm Hg. In roughly 40% of encountered cases, however, Doppler echocardiography yields discordant findings—a calculated AVA suggestive of severe AS but a MG consistent with less-than-severe disease [1,2]. Assuming no error in measurement, these cases stem, in part, from low-flow states (defined as a resting stroke volume index, SVI, less than or equal to 35 mL/m2) and cons...
Source: International Journal of Cardiology - March 22, 2021 Category: Cardiology Authors: James W. Lloyd, Mackram F. Eleid Tags: Editorial Source Type: research
Revascularization or medical therapy for stable coronary artery disease: To do or not to do, that is the question
Cardiovascular diseases (CVDs) are the most common cause of death globally. In 2016, a total of 17.9 million people died due to CVDs; of them, heart attack and stroke accounted for 85% [1]. Ischemic heart disease is mainly caused by inadequate blood supply to the myocardium owing to atherosclerotic narrowing of coronary artery diseases (CADs). The central goal in the management of patients with stable CAD is to alleviate angina symptoms as well as prevent future cardiovascular events such as myocardial infarction (MI) or death from cardiovascular causes.
Source: International Journal of Cardiology - December 21, 2020 Category: Cardiology Authors: Junghoon Lee, Duk-Woo Park Tags: Editorial Source Type: research
Temporal trends of atrial fibrillation and/or rheumatic heart disease-related ischemic stroke, and anticoagulant use in Chinese population: An 8-year study
Underuse of anticoagulants in ischemic stroke patients with atrial fibrillation (AF) and/or rheumatic heart disease (RHD) is a global concern, especially in China. However, the extent to which anticoagulants are underused in AF and/or RHD-related ischemic stroke in China has not been well characterized. We aimed to explore the temporal trends of AF and/or RHD-related ischemic stroke patients, anticoagulation use and factors related to suboptimal use of anticoagulants in a Chinese population.
Source: International Journal of Cardiology - August 15, 2020 Category: Cardiology Authors: Junfeng Liu, Yanan Wang, Wen Guo, Yajun Cheng, Shihong Zhang, Bo Wu, Ming Liu Source Type: research
NOACs in adult congenital heart disease – Still limited experience
With advances in congenital heart disease treatment, more patients with repaired or palliated defects are living longer [1]. Adult congenital heart disease (ACHD) is also associated with an increased risk of atrial fibrillation [2] and stroke, both haemorrhagic and embolic [3,4]. While there is an abundance of clinical trials evaluating novel oral anticoagulants, NOACs, in patients with acquired heart disease the opposite is true for ACHD. In the current issue, Pujol and co-workers [5] report their single centre experience of 215 ACHD patients treated with NOACs.
Source: International Journal of Cardiology - November 18, 2019 Category: Cardiology Authors: Mikael Dellborg, Zacharias Mandalenakis Tags: Editorial Source Type: research
A national study of the prevalence and risk factors associated with peripheral arterial disease from China: The China Hypertension Survey, 2012 –2015
Peripheral arterial disease (PAD) is the third leading cause of atherosclerotic vascular morbidity after coronary heart disease and stroke. Epidemiology data of PAD is very limited in low-income and middle-income countries. A national wide survey was conducted from October 2012 to December 2015 to assess the prevalence of PAD in China.
Source: International Journal of Cardiology - October 25, 2018 Category: Cardiology Authors: Zengwu Wang, Xin Wang, Guang Hao, Zuo Chen, Linfeng Zhang, Lan Shao, Ye Tian, Ying Dong, Congyi Zheng, Yuting Kang, Runlin Gao, China hypertension survey investigators Source Type: research
Lipid intervention in diabetes, metabolic syndrome and beyond
Substantial data during the last three decades has focused on lipid intervention for the prevention and treatment of atherosclerosis and, more importantly, on the primary and secondary prevention of major cardiovascular disease (CVD) events, including coronary heart disease (CHD) and stroke [1]. Certainly, the majority of the attention during recent decades has been directed at lowering the levels of low-density lipoprotein cholesterol (LDL-C), although some studies have also directed attention at lowering levels of triglycerides (TGs) and/or raising levels of the cardio-protective high-density lipoprotein cholesterol (HDL-C).
Source: International Journal of Cardiology - July 22, 2018 Category: Cardiology Authors: Carl J. Lavie, Richard V. Milani, James H. O'Keefe Tags: Editorial Source Type: research
Stroke, thromboembolism and bleeding in patients with atrial fibrillation according to the EHRA valvular heart disease classification
We compared thromboembolic (TE) and bleeding risks in patients with atrial fibrillation (AF) according to the new ‘Evaluated Heartvalves, Rheumatic or Artificial’ (EHRA) valve classification.
Source: International Journal of Cardiology - March 7, 2018 Category: Cardiology Authors: Arnaud Bisson, Alexandre Bodin, Nicolas Clementy, Anne Bernard, Dominique Babuty, Gregory Y.H. Lip, Laurent Fauchier Source Type: research
The impact of migration on cardiovascular diseases
Cardiovascular disease (CVD) is now the leading contributor to disability-adjusted life years lost worldwide [1]. Within CVD, ischaemic heart disease and stroke rank first and second [1], with hypertensive heart disease and heart failure, rheumatic heart disease (RHD), cardiomyopathy and atrial fibrillation also contributing substantially [2]. There is clear international commitment to address this issue. The WHO 25 ×25 Global Action Plan [3], and the Sustainable Development Goals [4] set ambitious targets to reduce premature mortality from CVD.
Source: International Journal of Cardiology - January 29, 2018 Category: Cardiology Authors: Anna Odone, Charlotte McKee, Martin McKee Tags: Editorial Source Type: research
Should small-to-moderate alcohol consumption be recommended for healthy middle-aged women?
Sex-specific differences may exist in the association of alcohol consumption and atrial fibrillation. The article by Gallagher et al. [1] demonstrated that significant associations between moderate alcohol consumption and increased risk of atrial fibrillation among men but not among women. Low alcohol consumption is not associated with an increased risk of atrial fibrillation in both genders. Light to moderate alcohol consumption has been consistently associated with reduced risks of coronary heart disease, stroke, and congestive heart failure.
Source: International Journal of Cardiology - November 30, 2017 Category: Cardiology Authors: Yang Yang, Die Hu, Daoquan Peng Tags: Letter to the Editor Source Type: research
Physician deaths from overwork should arouse greater attention in China
With great interest we read Dr. Wong's paper published in November 2016 in International Journal of Cardiology [1]. They concluded that sleep deprivation or overwork could be a proarrhythmic factor for idiopathic ventricular fibrillation. Besides, some researchers also found that overwork has been associated with an increase in the risk of heart disease, stroke, medical accidents and errors, threatened abortion and preterm birth, as well as a decrease in quality of patient care [2,3].
Source: International Journal of Cardiology - October 18, 2017 Category: Cardiology Authors: Yan-Fei Shen, Xiang-Yong Hao, Tian-Kang Guo Tags: Letter to the Editor Source Type: research
Impact of atrial arrhythmias on outcome in adults with congenital heart disease
Adults with congenital heart disease (ACHD) are affected by atrial arrhythmias (AA). To elucidate the impact of AA on prognosis, we aimed to determine the impact of AA on death, heart failure and stroke in ACHD patients in a prospective nationwide clinical registry.
Source: International Journal of Cardiology - September 22, 2017 Category: Cardiology Authors: H. Yang, J.M. Kuijpers, J.R. de Groot, T.C. Konings, A. van Dijk, G.Tj. Sieswerda, M.C. Post, B.J.M. Mulder, B.J. Bouma Tags: Short communication Source Type: research
Effects of early age at natural menopause on coronary heart disease and stroke in Chinese women
The objective of the study was to explore the associations between early age at natural menopause (menopause at an age ≤45 years) and the presence of CHD and stroke.
Source: International Journal of Cardiology - March 29, 2017 Category: Cardiology Authors: Lijun Shen, Lulu Song, Bingqing Liu, Hui Li, Xiaoxuan Zheng, Lina Zhang, Jing Yuan, Yuan Liang, Youjie Wang Source Type: research
Left atrial appendage closure in a patient with left atrial appendage thrombus using a novel fish ball technique
We report on a 47-year-old (body-mass-index 24, 8), male patient who was scheduled for percutaneous left atrial appendage (LAA) closure at our hospital. In this patient permanent atrial fibrillation was known since 2010 with a CHA2DS2-Vasc-score of 3, because of arterial hypertension, diabetes mellitus type II and coronary heart disease). The Hasbled-score was 4, because of arterial hypertension, bleeding and stroke in his history and labile INR values under anticoagulation with warfarin therapy.
Source: International Journal of Cardiology - December 26, 2016 Category: Cardiology Authors: Barbara Bellmann, Andreas Rillig, David Leistner, Mario Kasner, Carsten Skurk, Ulf Landmesser, Jai-Wun Park Source Type: research
Non-vitamin K oral anticoagulant treatment in elderly patients with atrial fibrillation and coronary heart disease
Atrial fibrillation (AF) is the most frequent sustained arrhythmia. Overall prevalence is estimated to 5.5% and the incidence increases with age. As the population ages, the prevalence and costs of AF are expected to increase. AF is the most important cause of stroke in patients>75years. Until recently, Vitamin K antagonists (VKAs) were the only available oral anticoagulants (OACs) evaluated for long-term treatment of patients with AF with or without coronary heart disease (CHD). This situation was challenged by introduction of non-VKA oral anticoagulants (NOACs).
Source: International Journal of Cardiology - August 3, 2016 Category: Cardiology Authors: Xavier Humbert, Vincent Roule, Mathieu Chequel, Sophie Fedrizzi, Marie Brionne, V éronique Lelong-Boulouard, Paul Milliez, Joachim Alexandre Tags: Review Source Type: research
